Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Appendicitis | Review

Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature

Authors: Shuming Jiang, Jianfei E, Dengchao Wang, Yanjiao Zou, Xiao Liu, Hualiang Xiao, Yuan Wen, Zongyao Chen

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Eggerthella lenta is a normal human microflora that is anaerobic, non-sporulating, and Gram positive. However, an increasing number of studies have shown that it could also be an important pathogen for humans, even causing life-threatening infection under certain conditions. However, understanding its pathogenic mechanism and treatment options still need to be improved; more clinical data are needed to explore it further. In this article, we report a case of ceftizoxime-cured E. lenta bacteremia and review the recent literature to provide more clinical data for the diagnosis of E. lenta bacteremia. Our report suggests that the frequency of E. lenta bacteremia is increased in patients with hematologic or solid organ cancer, diabetes mellitus and also in those with appendicitis.
Literature
1.
Eggerth A. The Gram-positive non-spore-bearing Anaerobic Bacilli of human feces. J Bacteriol. 1935;30(3):277–99.CrossRef
2.
Lau S, Woo P, Woo G, et al. Eggerthella hongkongensis sp. nov. and Eggerthella sinensis sp. nov., two novel Eggerthella species, account for half of the cases of Eggerthella bacteremia. Diagn Microbiol Infect Dis. 2004;49(4):255–63.CrossRef
3.
Barreau M, Pagnier I, la Scola B. Improving the identification of anaerobes in the clinical microbiology laboratory through MALDI-TOF mass spectrometry. Anaerobe. 2013;22:123–5.CrossRef
4.
Schmitt B, Cunningham S, Dailey A, et al. Identification of anaerobic bacteria by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry with on-plate formic acid preparation. J Clin Microbiol. 2013;51(3):782–6.CrossRef
5.
Lee M-R, Huang Y-T, Liao C-H, et al. Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a University Hospital in Taiwan from 2001 to 2010. J Clin Microbiol. 2012;50(6):2053–5.CrossRef
6.
Liderot K, Larsson M, Borang S, et al. Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans. J Clin Microbiol. 2010;48(10):3810–2.CrossRef
7.
Bo J, Wang S, Bi Y, et al. Eggerthella lenta bloodstream infections: two cases and review of the literature. Future Microbiol. 2020;15:981–5.CrossRef
8.
Elias R, Khoo S, Pupaibool J, et al. Multiple pyogenic liver abscesses caused by Eggerthella lenta treated with Ertapenem: a case report. Case Rep Med. 2012;2012:718130.CrossRef
9.
Shipitsyna E, Roos A, Datcu R, et al. Composition of the vaginal microbiota in women of reproductive age-sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PloS ONE. 2013;8(4):e60670.CrossRef
10.
Gardiner BJ, Korman TM, Junckerstorff RK. Eggerthella lenta bacteremia complicated by spondylodiscitis, psoas abscess, and meningitis. J Clin Microbiol. 2014;52(4):1278–80.CrossRef
11.
Jiang J, She B, Zheng R. Bacteremia caused by the Eggerthella lenta in a previously healthy 30-year-old man with acute suppurative appendicitis: a case report from China. Infect Drug Resist. 2020;13:3695–8.CrossRef
12.
Lattuada E, Zorzi A, Lanzafame M, et al. Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature. J Infect. 2005;51(2):E71-72.CrossRef
13.
Bok C, Ng Y. Eggerthella lenta as a cause of anaerobic spondylodiscitis. Singapore Med J. 2009;50(12):e393-396.PubMed
14.
Moon T, Lin R, Jahn A. Fatal frontal sinusitis due to Neisseria sicca and Eubacterium lentum. J Otolaryngol. 1986;15(3):193–5.PubMed
15.
Palomino-Nicás J, González E, Arroyo A, et al. Pyomyositis due to Eubacterium lentum and Streptococcus constellatus from a periodontal source. Clin Infect Dis. 1996;22(1):176–8.CrossRef
16.
Gardiner BJ, Tai AY, Kotsanas D, et al. Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J Clin Microbiol. 2015;53(2):626–35.CrossRef
17.
Venugopal AA, Szpunar S, Johnson LB. Risk and prognostic factors among patients with bacteremia due to Eggerthella lenta. Anaerobe. 2012;18(4):475–8.CrossRef
18.
Woerther PL, Antoun S, Chachaty E, et al. Eggerthella lenta bacteremia in solid tumor cancer patients: pathogen or witness of frailty? Anaerobe. 2017;47:70–2.CrossRef
19.
Wong D, Aoki F, Rubinstein E. Bacteremia caused by Eggerthella lenta in an elderly man with a gastrointestinal malignancy: a case report. Can J Infect Dis Med Microbiol. 2014;25(5):e85-86.CrossRef
20.
Salameh A, Klotz SA, Zangeneh TT. Disseminated infection caused by Eggerthella lenta in a previously healthy young man: a case report. Case Rep Infect Dis. 2012;2012:1–3.
21.
Fatima T, Hasan R, Tariq S. Eggerthella lenta bacteremia in endometrial adenocarcinoma—a case report from Pakistan. J Pak Med Assoc. 2020;70(6):1079–80.PubMed
22.
Thota V, Dacha S, Natarajan A, et al. Eggerthella lenta bacteremia in a Crohn’s disease patient after ileocecal resection. Future Microbiol. 2011;6(5):595–7.CrossRef
23.
Lee HJ, Hong SK, Choi WS, et al. The first case of Eggerthella lenta bacteremia in Korea. Ann Lab Med. 2014;34(2):177–9.CrossRef
24.
Mal P, Rafiq I, Iftikhar I, et al. Pelvic abscess caused by a slow growing anaerobic bacterium, Eggerthella lenta: first case report from Pakistan. J Pak Med Assoc. 2017;67(10):1604–5.PubMed
25.
Priputnevich T, Lyubasovskaya L, Muravieva V, et al. Postpartum endometritis and obstetrical sepsis associated with Eggerthella lenta. Case report and review of the literature. J Matern Fetal Neonatal Med. 2019;34(2):313–7.CrossRef
26.
Cordoba G, Kim ML, Sharma S, et al. Septic shock caused by the under-recognized bacterium Eggerthella lenta in a 61-year-old male with a periurethral abscess: a case report. Rev Soc Bras Med Trop. 2019;52:e20190081.CrossRef
27.
Ugarte-Torres A, Gillrie MR, Griener TP, et al. Eggerthella lenta bloodstream infections are associated with increased mortality following empiric piperacillin-tazobactam (TZP) monotherapy: a population-based cohort study. Clin Infect Dis. 2018;67(2):221–8.CrossRef
28.
Liderot K, Ratcliffe P, Luthje P, et al. Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: rapid identification and antimicrobial susceptibility profile. Anaerobe. 2016;38:21–4.CrossRef
29.
Jehangir W, Sanabria F, Singh Z, et al. Enteric fistulous communication with an aortobifemoral graft permitting for Eggerthella lenta colonization. J Glob Infect Dis. 2015;7(4):170–2.CrossRef
30.
Elias R, Khoo S, Pupaibool J, et al. Multiple pyogenic liver abscesses caused by Eggerthella lenta treated with ertapenem: a case report. Case Rep Med. 2012;2012:718130.CrossRef
31.
Goupil R, Nadeau-Fredette A, Tennankore K, et al. Peritonitis caused by veillonella species and Eggerthella lenta in peritoneal dialysis. Perit Dial Int. 2014;34(2):245–7.CrossRef
32.
Declerck B, Van der beken Y, de Geyter D, et al. Antimicrobial susceptibility testing of Eggerthella lenta blood culture isolates at a university hospital in Belgium from 2004 to 2018. Anaerobe. 2021;69:102348.CrossRef
33.
Canadian Medical Association. Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria Committee on Antimicrobial Agents, Canadian Infectious Disease Society. Can Med Assoc J. 1990;142(11):1209–12.
34.
Mosca A, Summanen P, Finegold SM, et al. Cellular fatty acid composition, soluble-protein profile, and antimicrobial resistance pattern of Eubacterium lentum. J Clin Microbiol. 1998;36(3):752–5.CrossRef
Metadata
Title
Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature
Authors
Shuming Jiang
Jianfei E
Dengchao Wang
Yanjiao Zou
Xiao Liu
Hualiang Xiao
Yuan Wen
Zongyao Chen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00582-y

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue

Research

Dickkopf-related protein 3 alters aerobic glycolysis in pancreatic cancer BxPC-3 cells, promoting CD4+ T-cell activation and function

Research

The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome

Research

Safety of elective abdominal and vascular surgery during the COVID-19 pandemic: a retrospective single-center study

Research

Study on clinical nursing pathway to promote the effective implementation of sepsis bundle in septic shock

Research

An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2

Research

The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review